Viewing nowZenvigsaeng 10 milligrams (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Poonglim Pharmaceutical Co., Ltd.

MFDS item code 202002221 · Approved 2020.03.31 · Insurance code 649002310
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease.
This drug is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg once daily for 7 days. Week 2 (Days 8–14) Administer 10mg once daily for 7 days. Week 3 (Days 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.
This medication should not be used in individuals allergic to its components. It is also advisable not to administer it to patients with severely impaired liver function or very compromised kidney function. Special care should be taken when using this medication in patients with epilepsy, those who have had seizures in the past, or those at risk of seizures. Co-administration with certain medications like amantadine, ketamine, and dextromethorphan may exacerbate side effects, so it is advisable not to take them together. Patients should carefully monitor their urine status when there are changes in urine acidity or dietary habits. Individuals with recent heart disease or uncontrolled hypertension should consult their physician about the use of this medication. During treatment, symptoms such as dizziness, headache, constipation, drowsiness, and increased blood pressure may occur; patients should inform their healthcare provider if symptoms are severe. There may be interactions with other medications, so patients must inform their healthcare provider about all medications they are taking, particularly when using anticoagulants or muscle relaxants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and breastfeeding women are advised to discontinue nursing. The safety and efficacy of this medication have not been established in children and adolescents under 18 years of age, so its use is discouraged. In case of overdose, symptoms such as confusion, drowsiness, dizziness, hallucinations, and vomiting may occur, and immediate medical attention should be sought. This medication may affect the central nervous system, requiring caution when driving or operating machinery. It must be stored out of reach of children, and transferring it to another container should be avoided to maintain the quality and safety of the medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.
Pale yellow to yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Poonglim Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.